ask="N/A"
ask_size="N/A"
average_daily_volume="31856"
bid="3.12"
bid_size="100"
book_value="3.34"
change="-0.01"
change_from_200_day_moving_average="1.39"
change_from_50_day_moving_average="1.03"
change_from_52_week_high="-1.79"
change_From_52_week_low="4.48"
change_in_percent="-0.12%"
close="8.00"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-2.26"
ebitda="-50.28M"
eps_estimate_current_year="-2.60"
eps_estimate_next_quarter="-0.63"
eps_estimate_next_year="-2.85"
ex_dividend_date="N/A"
float_shares="686000"
high="8.10"
high_52_weeks="9.79"
last_trade_date="2/3/2017"
last_trade_price="8.00"
last_trade_size="4702"
last_trade_time="4:00pm"
low="7.87"
low_52_weeks="3.52"
market_capitalization="170.24M"
moving_average_200_day="6.61"
moving_average_50_day="6.97"
name="Nabriva Therapeutics AG - Ameri"
notes="N/A"
one_year_target_price="16.25"
open="7.92"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="+20.96%"
percent_change_from_50_day_moving_average="+14.83%"
percent_change_from_52_week_high="-18.26%"
percent_change_from_52_week_low="+127.27%"
previous_close="8.01"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="2.40"
price_per_sales="32.78"
revenue="5.20M"
shares_outstanding="21280000"
short_ratio="3.92"
stock_exchange="NMS"
symbol="NBRV"
volume="39087"
weeks_range_52="3.52 - 9.79"
